Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine Rochester, MN, USA ; Neurobiology of Disease Program, Mayo Clinic College of Medicine Rochester, MN, USA.
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine Rochester, MN, USA ; Department of Psychiatry, Sanggye Paik Hospital, College of Medicine, InJe University Seoul, South Korea.
Front Neurosci. 2014 Sep 18;8:288. doi: 10.3389/fnins.2014.00288. eCollection 2014.
Peptides synthesized in endocrine cells in the gastrointestinal tract and neurons are traditionally considered regulators of metabolism, energy intake, and appetite. However, recent work has demonstrated that many of these peptides act on corticostriatal-limbic circuitry and, in turn, regulate addictive behaviors. Given that alcohol is a source of energy and an addictive substance, it is not surprising that increasing evidence supports a role for gut-brain peptides specifically in alcohol use disorders (AUD). In this review, we discuss the effects of several gut-brain peptides on alcohol-related behaviors and the potential mechanisms by which these gut-brain peptides may interfere with alcohol-induced changes in corticostriatal-limbic circuitry. This review provides a summary of current knowledge on gut-brain peptides focusing on five peptides: neurotensin, glucagon-like peptide 1, ghrelin, substance P, and neuropeptide Y. Our review will be helpful to develop novel therapeutic targets for AUD.
胃肠道内分泌细胞和神经元中合成的肽类传统上被认为是代谢、能量摄入和食欲的调节剂。然而,最近的研究表明,许多这些肽类作用于皮质纹状体边缘回路,并反过来调节成瘾行为。鉴于酒精是能量的来源和成瘾物质,越来越多的证据支持肠道-脑肽在酒精使用障碍(AUD)中的作用也就不足为奇了。在这篇综述中,我们讨论了几种肠道-脑肽对与酒精相关的行为的影响,以及这些肠道-脑肽可能通过哪些潜在机制干扰酒精引起的皮质纹状体边缘回路变化。这篇综述提供了对肠道-脑肽的当前知识的总结,重点介绍了五种肽:神经降压素、胰高血糖素样肽 1、胃饥饿素、P 物质和神经肽 Y。我们的综述将有助于为 AUD 开发新的治疗靶点。